The details bedevil DCOR.

Kidney Int

Minerva Center for Calcium and Bone Metabolism, Nephrology and Hypertension Services, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Published: November 2007

Calcium-free oral phosphorus binders were heralded as a striking new development for patients with chronic kidney disease, promising a reduction in morbidity and mortality from cardiovascular disease. Sevelamer hydrochloride was the first such drug introduced to the market. Dialysis Clinical Outcomes Revisited (DCOR) is an outcomes study on the effect of sevelamer compared with calcium-based phosphorus binders in dialysis patients. It does not show a clear superiority of one compound over the other.

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.ki.5002527DOI Listing

Publication Analysis

Top Keywords

phosphorus binders
8
details bedevil
4
bedevil dcor
4
dcor calcium-free
4
calcium-free oral
4
oral phosphorus
4
binders heralded
4
heralded striking
4
striking development
4
development patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!